Form EFFECT Coherus Oncology, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 8, 2025 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coherus Oncology hires Oppenheimer to sell biosimilar assets
- IKS Health's 2026 Documentation, Coding and Revenue Cycle Leadership Spotlighted Ahead of AHIMA26 by Black Book
- Forvis Mazars highlights sustained growth, strategic investments in 2026 Integrated Report
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
